Internal Medicine

3151 questions

All types3,151 Multiple choice1,611 Multiple select73 Numeric81 Matching714 Ordering672

A 54-year-old woman is brought to the emergency department by her husband due to a severe headache, blurry vision, and worsening shortness of breath over the past 48 hours. She was diagnosed with diffuse cutaneous systemic sclerosis 3 years ago. Her current medications include mycophenolate mofetil, low-dose prednisone, and omeprazole. Her temperature is 37.0°C (98.6°F), blood pressure is 226/118 mm Hg, pulse is 112/min, and respirations are 26/min. Oxygen saturation is 91% on room air. Physical examination reveals thickened, tethered skin over her face, chest, and proximal extremities. Cardiopulmonary auscultation reveals a prominent S4 gallop and bilateral basilar crackles.

Laboratory results are as follows:

Parameter	Value	Reference Range
Hemoglobin	$9.1 \text{ g/dL}$	$12.0-16.0 \text{ g/dL}$
Platelet count	$98,000/\text{mm}^3$	$150,000-400,000/\text{mm}^3$
Serum creatinine	$3.6 \text{ mg/dL}$ (Baseline: $0.9 \text{ mg/dL}$ )	$0.6-1.2 \text{ mg/dL}$
Blood urea nitrogen	$52 \text{ mg/dL}$	$7-18 \text{ mg/dL}$
Serum sodium	$136 \text{ mEq/L}$	$136-145 \text{ mEq/L}$
Serum potassium	$4.8 \text{ mEq/L}$	$3.5-5.0 \text{ mEq/L}$
Serum chloride	$104 \text{ mEq/L}$	$98-106 \text{ mEq/L}$
Serum bicarbonate	$14 \text{ mEq/L}$	$22-28 \text{ mEq/L}$
Arterial blood gas (room air)	$\text{pH } 7.31, p\text{CO}_2 \text{ } 29 \text{ mm Hg}, p\text{O}_2 \text{ } 62 \text{ mm Hg}$
Serum TSH	$0.9 \text{ } \mu\text{U/mL}$	$0.5-5.0 \text{ } \mu\text{U/mL}$
Serum free T4	$0.6 \text{ ng/dL}$	$0.9-1.7 \text{ ng/dL}$

A peripheral blood smear demonstrates 4 to 5 schistocytes per high-power field.

Which of the following is the most appropriate next step in the management of this patient?

Initiate therapy with captopril

Administer intravenous furosemide and noninvasive positive-pressure ventilation

Administer empiric broad-spectrum intravenous antibiotics

Administer an intravenous sodium bicarbonate infusion

Initiate therapy with oral levothyroxine

Show answer & explanation

Answer: Initiate therapy with captopril

Answer

The most appropriate next step is to initiate therapy with captopril.

The correct approach is to initiate therapy with captopril. This patient is presenting with scleroderma renal crisis (SRC), a life-threatening complication of diffuse cutaneous systemic sclerosis. SRC is characterized by the sudden onset of malignant hypertension, acute kidney injury (AKI), and microangiopathic hemolytic anemia (evidenced by schistocytes and thrombocytopenia on the peripheral smear). The underlying pathophysiology involves acute renal vascular injury leading to ischemia and massive, unchecked activation of the renin-angiotensin-aldosterone system (RAAS). Therefore, rapid RAAS blockade with a short-acting angiotensin-converting enzyme (ACE) inhibitor, such as captopril, is the definitive treatment. Paradoxically, while ACE inhibitors are generally withheld in patients with AKI due to the risk of worsening renal perfusion, they are the standard of care for SRC and are the only medications proven to improve mortality and preserve long-term renal function in this condition.

Step-by-Step Solution

Identify the primary acute syndrome based on the clinical presentation and laboratory findings.

The patient exhibits malignant hypertension, acute kidney injury (AKI), and microangiopathic hemolytic anemia (schistocytes, thrombocytopenia) in the context of diffuse cutaneous systemic sclerosis.

These findings form the classic clinical triad for scleroderma renal crisis (SRC).

Determine the underlying pathophysiology driving the syndrome.

SRC is caused by acute renal vascular intimal proliferation and ischemia, leading to massive, unchecked activation of the renin-angiotensin-aldosterone system (RAAS).

Understanding the RAAS-driven mechanism is essential for selecting the targeted pharmacotherapy to halt the process.

Select the optimal pharmacological intervention to interrupt the disease progression.

A short-acting angiotensin-converting enzyme (ACE) inhibitor, such as captopril, must be administered immediately.

Although ACE inhibitors are typically contraindicated in the setting of acute kidney injury, they are uniquely life-saving in SRC and are the only class of medication proven to restore renal function and prevent mortality in this specific crisis.

Key Concept

Scleroderma renal crisis presents with acute malignant hypertension, acute kidney injury, and microangiopathic hemolytic anemia; it must be treated immediately with an ACE inhibitor (e.g., captopril), even in the setting of acute kidney injury.

Question 1282Question →

A $65$ -year-old man is evaluated in the hospital for new-onset right lower extremity swelling and pain. He underwent a complex open cholecystectomy and lysis of adhesions $7$ days ago. His postoperative course was complicated by a superficial wound infection, which is currently being treated with targeted antibiotic therapy. Since the day of surgery, he has been receiving subcutaneous unfractionated heparin for deep venous thrombosis prophylaxis.

Vital signs include a temperature of $37.2^\circ\text{C}$ ( $99.0^\circ\text{F}$ ), heart rate of $92/\text{min}$ , and blood pressure of $130/80\text{ mm Hg}$ . Physical examination reveals a swollen, erythematous, and tender right calf.

Laboratory studies show the following:

Test	Result
Hemoglobin	$11.2 \text{ g/dL}$
Leukocyte count	$8,500/\mu\text{L}$
Platelet count	$95,000/\mu\text{L}$
Preoperative platelet count	$220,000/\mu\text{L}$
Creatinine	$1.1 \text{ mg/dL}$

Lower extremity venous duplex ultrasonography reveals a noncompressible right popliteal vein.

Which of the following is the most appropriate next step in management?

Discontinue unfractionated heparin and start argatroban

Discontinue unfractionated heparin and start enoxaparin

Discontinue unfractionated heparin and start warfarin

Continue unfractionated heparin and start a therapeutic-dose continuous infusion

Administer pooled platelets and discontinue unfractionated heparin

Show answer & explanation

Answer: Discontinue unfractionated heparin and start argatroban

Answer

The most appropriate next step in management is to discontinue unfractionated heparin and start argatroban.

The correct action is to discontinue unfractionated heparin and initiate a direct thrombin inhibitor (e.g., argatroban). This patient has classic Type 2 Heparin-Induced Thrombocytopenia (HIT), defined by a fall in platelet count of

>50\%

occurring

5

10

days after heparin initiation, alongside a new thrombotic event (popliteal DVT). Pathophysiologically, IgG antibodies form against the heparin-platelet factor 4 (PF4) complex. These immune complexes bind to platelet surfaces, causing widespread platelet activation, consumption (leading to thrombocytopenia), and massive thrombin generation (leading to arterial and venous thrombosis). The absolute priority is to halt the immune trigger by stopping all heparin exposure and to provide immediate therapeutic anticoagulation using an alternative non-heparin agent (e.g., argatroban, bivalirudin, fondaparinux) to manage the profound prothrombotic state.

Step-by-Step Solution

Analyze the timeline and laboratory values.

The patient experienced a

>50\%

decrease in his platelet count (from

220,000/\mu\text{L}

95,000/\mu\text{L}

) over

7

days while exposed to unfractionated heparin.

Identifying the temporal relationship between heparin exposure (

5

10

days) and significant thrombocytopenia (

>50\%

drop) is required to clinically suspect Heparin-Induced Thrombocytopenia (HIT).

Correlate laboratory findings with the clinical presentation.

The patient presents with a new right popliteal deep venous thrombosis (DVT) concurrently with the thrombocytopenia.

HIT is a highly prothrombotic state (Type 2 HIT). The presence of a new arterial or venous thrombosis confirms the severe clinical consequence of the antibody-mediated platelet activation.

Determine the immediate therapeutic intervention.

All heparin products must be stopped immediately, and a non-heparin anticoagulant must be initiated to treat the acute thrombosis.

Continuing heparin fuels the underlying pathophysiology, while an alternative fast-acting anticoagulant (like argatroban) is essential to prevent extension of the DVT and fatal complications like pulmonary embolism.

Key Concept

Patients who develop a >50% drop in platelets or new thrombosis 5-10 days after heparin exposure likely have Heparin-Induced Thrombocytopenia (HIT). Management requires immediate cessation of all heparin products (including LMWH) and initiation of a non-heparin anticoagulant like argatroban, bivalirudin, or fondaparinux.

Estimated Time:1m 30s

Question 1283Question →

A 65-year-old man comes to the office due to sudden, severe pain and swelling in his right big toe that began early this morning. He reports that the pain is so intense he cannot tolerate a bedsheet touching the foot. His medical history includes hypertension, diet-controlled type 2 diabetes mellitus, and stage 4 chronic kidney disease with a baseline serum creatinine of 2.8 mg/dL. His medications include amlodipine and bumetanide. Vital signs are within normal limits. Examination of the right foot shows a swollen, warm, dusky red, and exquisitely tender first metatarsophalangeal joint. Arthrocentesis yields cloudy yellow synovial fluid. Analysis of the fluid demonstrates a leukocyte count of 35,000/mm³ with 85% neutrophils. Polarized light microscopy reveals numerous needle-shaped crystals with strong negative birefringence. Which of the following is the most appropriate treatment for this patient's current condition?

Intra-articular triamcinolone

Oral indomethacin

Oral colchicine

Oral allopurinol

Intravenous vancomycin

Show answer & explanation

Answer: Intra-articular triamcinolone

Answer

Intra-articular triamcinolone

The correct answer provides localized, potent anti-inflammatory action without systemic toxicity. This patient is experiencing an acute gout flare, confirmed by the presence of needle-shaped, negatively birefringent crystals (monosodium urate) in the synovial fluid. The standard first-line therapies for acute gout include NSAIDs, colchicine, and systemic or intra-articular glucocorticoids. However, this patient has stage 4 chronic kidney disease. NSAIDs are strongly contraindicated as they can cause acute kidney injury. Colchicine requires extreme caution and dose adjustment in severe renal impairment, making it a less favorable choice. Systemic glucocorticoids could be used but may worsen glycemic control in his diabetes. An intra-articular injection of a glucocorticoid (such as triamcinolone) is highly effective for monoarticular flares and provides excellent localized relief while minimizing systemic absorption and renal risks.

Step-by-Step Solution

Diagnose the underlying condition based on clinical and laboratory findings.

The patient has an acute gout flare, evidenced by podagra (first metatarsophalangeal joint involvement) and synovial fluid showing negatively birefringent needle-shaped crystals.

Accurate diagnosis is required before initiating targeted therapy.

Evaluate the patient's comorbidities that affect pharmacologic management.

The patient has stage 4 chronic kidney disease (creatinine 2.8 mg/dL) and diabetes mellitus.

Comorbidities heavily dictate the safety profile of acute gout therapies.

Select the most appropriate treatment option avoiding contraindicated medications.

Intra-articular glucocorticoids (like triamcinolone) are chosen because NSAIDs and colchicine are contraindicated or highly risky in advanced renal failure.

Localized therapy resolves the acute inflammation effectively without exacerbating underlying renal dysfunction or causing systemic metabolic derangements.

Key Concept

Management of acute gout flares in patients with severe renal impairment requires avoiding NSAIDs and colchicine; intra-articular or systemic glucocorticoids are the preferred therapies.

Question 1284Question →

A 68-year-old man with a history of prostate cancer presents to the emergency department with progressively worsening lower back pain for the past two weeks. Today, he developed profound weakness in both legs and has been unable to urinate for the past 12 hours. Physical examination reveals motor strength of $3/5$ in the bilateral lower extremities, decreased pinprick sensation below the umbilicus, and hyperreflexia at the knees and ankles. The bladder is palpable above the pubic symphysis. Arrange the following management steps in the most appropriate chronological order for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first administer high-dose intravenous glucocorticoids, followed by performing an urgent MRI of the entire spine. After the diagnosis is confirmed by imaging, a neurosurgical or radiation oncology consultation should be obtained to plan and then initiate definitive decompressive therapy.

The patient's presentation of progressive back pain, lower extremity weakness, sensory level deficit, and urinary retention in the setting of known prostate cancer is highly suspicious for malignant epidural spinal cord compression. The absolute first step in management is the immediate administration of high-dose intravenous glucocorticoids (e.g., dexamethasone) to reduce peritumoral edema and prevent irreversible neurologic injury. This must be done immediately. Once steroids are given, an urgent MRI of the entire spine is performed to confirm the diagnosis and delineate the extent of the disease. Following imaging confirmation, urgent consultation with neurosurgery or radiation oncology is obtained to plan definitive therapy (surgery or radiation), which is then executed as the final acute step.

Step-by-Step Solution

Administer high-dose intravenous glucocorticoids

Rapid reduction of vasogenic edema surrounding the spinal cord.

Immediate preservation of neurologic function is the highest priority upon clinical suspicion, and this sight- or limb-saving therapy must not be delayed for imaging.

Perform urgent magnetic resonance imaging (MRI) of the entire spine

Visualization of the spinal cord and surrounding structures.

Confirms the diagnosis, locates the exact level of compression, and identifies any subclinical secondary lesions, which is required for definitive treatment planning.

Obtain urgent neurosurgical or radiation oncology consultation

Expert evaluation of imaging and patient clinical status.

Necessary to decide between surgical decompression versus radiation therapy based on tumor type, spinal stability, and patient operative risk.

Initiate definitive surgical decompression or targeted radiation therapy

Relief of mechanical pressure on the spinal cord.

Provides long-term preservation of neurologic function, prevents further deterioration, and assists with pain control.

Key Concept

In suspected malignant epidural spinal cord compression, high-dose intravenous corticosteroids must be administered immediately upon clinical suspicion, prior to obtaining confirmatory neuroimaging.

Estimated Time:1m 30s

Question 1285Question →

A middle-aged patient with stage 3 chronic kidney disease is evaluated for a maximally swollen, erythematous, and exquisitely tender first metatarsophalangeal joint. This marks the third similar episode within the past twelve months. Previous synovial fluid analysis definitively identified negatively birefringent, needle-shaped crystals. The attending physician outlines a comprehensive pharmacological protocol aimed at resolving the current symptoms and eventually depleting the total body urate pool. Arrange the following therapeutic steps in the correct chronological sequence, from immediate acute management to long-term maintenance.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: 1) Administer an oral glucocorticoid taper, 2) Initiate a xanthine oxidase inhibitor with anti-inflammatory prophylaxis, 3) Titrate the medication to achieve a serum uric acid

< 6.0

mg/dL, and 4) Cease the prophylactic agent after months of target maintenance.

The correct sequence reflects the standard stepwise approach to chronic gout management in patients with renal impairment. Acute inflammation is first controlled with renal-safe agents (glucocorticoids). Subsequently, urate-lowering therapy is initiated alongside prophylaxis to prevent mobilization flares. The urate-lowering therapy is then actively titrated to a specific biochemical target. Finally, once clinical stability is achieved, prophylaxis is withdrawn to minimize long-term medication burden.

Step-by-Step Solution

Control the acute flare with a renal-safe agent (oral glucocorticoids).

Complete resolution of acute joint inflammation and pain.

Acute flares must be resolved prior to focusing on long-term management. Glucocorticoids are preferred over NSAIDs or full-dose colchicine in patients with stage 3 chronic kidney disease.

Start a xanthine oxidase inhibitor (e.g., allopurinol) with concurrent low-dose prophylaxis.

Reduction of systemic urate production while preventing acute mobilization flares.

Rapid decreases in serum urate can precipitate paradoxical attacks; thus, low-dose prophylaxis (e.g., prednisone or adjusted-dose colchicine) is required when initiating urate-lowering therapy.

Titrate the xanthine oxidase inhibitor dose based on laboratory monitoring.

Serum urate decreases to the therapeutic target of

< 6.0

mg/dL.

Fixed-dose urate-lowering therapy is often insufficient; a treat-to-target approach is necessary to gradually dissolve existing monosodium urate crystal deposits.

Discontinue the prophylactic agent while continuing the xanthine oxidase inhibitor.

Patient remains on lifelong urate-lowering monotherapy without unnecessary drug toxicity.

Once the target urate level is sustained for 3 to 6 months without subsequent flares, the risk of mobilization flares drops significantly, rendering prophylaxis unnecessary.

Key Concept

The sequential pharmacological management of gout requires resolving the acute flare with comorbidity-appropriate agents, initiating treat-to-target urate-lowering therapy with concurrent prophylaxis, and eventually withdrawing prophylaxis once the urate target is durably maintained.

Estimated Time:1m 30s

Question 1286Question →

A 42-year-old man is hospitalized for community-acquired pneumonia. On admission, he presented with a temperature of 38.9°C (102.0°F), a productive cough, and a right lower lobe infiltrate on chest radiograph. He was empirically started on intravenous ceftriaxone and azithromycin. On hospital day 3, his temperature is 37.1°C (98.8°F), blood pressure is 122/78 mm Hg, pulse is 78/min, and oxygen saturation is 97% on room air. He is tolerating a regular diet and states he is feeling much better. Sputum cultures collected on admission have grown Streptococcus pneumoniae. Susceptibility testing shows the isolate is sensitive to penicillin, amoxicillin, ceftriaxone, levofloxacin, and vancomycin. Which of the following is the most appropriate next step in management?

Discontinue current antibiotics and start oral amoxicillin

Continue intravenous ceftriaxone and azithromycin

Discontinue current antibiotics and start oral levofloxacin

Discontinue current antibiotics and start oral amoxicillin-clavulanate

Discontinue current antibiotics and start intravenous ampicillin

Show answer & explanation

Answer: Discontinue current antibiotics and start oral amoxicillin

Answer

Discontinue current antibiotics and start oral amoxicillin

The patient has demonstrated significant clinical improvement, is hemodynamically stable, and is tolerating an oral diet. These factors make him an ideal candidate for intravenous-to-oral antibiotic transition. The sputum culture definitively identified Streptococcus pneumoniae that is sensitive to penicillin and amoxicillin. According to core principles of antimicrobial stewardship, empiric broad-spectrum therapy should be narrowed to the most targeted, effective agent available once susceptibility data returns. Oral amoxicillin provides excellent coverage for susceptible S. pneumoniae without inducing unnecessary broad-spectrum selection pressure.

Step-by-Step Solution

Evaluate the patient's clinical trajectory and stability on hospital day 3.

The patient is afebrile, hemodynamically stable, maintaining normal oxygen saturation on room air, and tolerating an oral diet.

Establishing clinical stability is the primary requirement for safely transitioning a patient from intravenous to oral antibiotics.

Analyze the sputum culture and susceptibility results to guide targeted therapy.

The identified pathogen is Streptococcus pneumoniae, which testing confirms is susceptible to narrow-spectrum beta-lactams including penicillin and amoxicillin.

Culture data allows clinicians to de-escalate from broad-spectrum empiric therapy to a targeted regimen, minimizing collateral damage to normal flora.

Select the most appropriate definitive therapeutic agent.

Oral amoxicillin is chosen to complete the treatment course.

It offers highly effective, targeted therapy against the susceptible isolate and facilitates safe hospital discharge.

Key Concept

Antibiotic stewardship principles dictate transitioning from broad-spectrum intravenous therapy to targeted, narrow-spectrum oral therapy once clinical stability is achieved and culture susceptibilities are known.

Estimated Time:1m 0s

Question 1287Question →

Emergency medical services bring an unresponsive 21-year-old university student to the emergency department. Her roommate reports she had been complaining of a severe headache, nausea, and photophobia for the past 24 hours. Vital signs show a temperature of 39.2°C (102.5°F), blood pressure of 90/60 mmHg, heart rate of 115/min, and respiratory rate of 22/min. Physical examination reveals marked nuchal rigidity and a diffuse non-blanching petechial rash on her lower extremities. Fundoscopic examination demonstrates bilateral papilledema.

Arrange the following diagnostic and therapeutic steps in the most appropriate chronological sequence for this patient's management.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The most appropriate chronological sequence is: 1) Obtain blood cultures, 2) Administer empiric antibiotics and dexamethasone, 3) Perform a CT scan of the head, 4) Perform a lumbar puncture.

This patient presents with a classic presentation of meningitis (fever, nuchal rigidity, altered mental status) and a petechial rash highly suspicious for meningococcemia. Due to the presence of papilledema and unresponsiveness, there is a high risk of brain herniation if a lumbar puncture is performed immediately. Therefore, a CT scan of the head is required prior to the procedure. However, initiating antimicrobial therapy is a medical emergency and must not be delayed while waiting for imaging. The correct sequence is to first draw blood cultures to maximize diagnostic yield, immediately administer empiric antibiotics (ceftriaxone, vancomycin) and dexamethasone, then proceed with the CT scan, and finally perform the lumbar puncture once mass effect has been ruled out.

Step-by-Step Solution

Draw peripheral blood cultures

Secures blood samples for microbiological testing.

Must be done first to guide targeted therapy, taking care not to significantly delay life-saving antibiotic administration.

Administer empiric antibiotics and dexamethasone

Provides immediate treatment for suspected bacterial meningitis.

Because the patient has papilledema and altered mental status, an immediate lumbar puncture is contraindicated. Antibiotics must never be delayed for neuroimaging in suspected bacterial meningitis.

Perform a non-contrast CT scan of the head

Evaluates for intracranial mass lesions, midline shift, or severe cerebral edema.

Required before a lumbar puncture in this patient due to signs of increased intracranial pressure (papilledema, altered mental status) to prevent brainstem herniation.

Perform a lumbar puncture

Obtains cerebrospinal fluid for cell count, chemistry, Gram stain, and culture.

Once the CT scan confirms the absence of mass effect, the lumbar puncture can be safely performed to definitively diagnose the central nervous system infection.

Key Concept

In patients with suspected bacterial meningitis who have indications for a CT scan before lumbar puncture (e.g., papilledema, altered mental status, focal neurologic deficits), blood cultures should be drawn immediately, followed by empiric antibiotics and corticosteroids, prior to sending the patient for the CT scan.

Estimated Time:1m 30s

Question 1288Question →

A $21$ -year-old woman is brought to the emergency department by her college roommate due to sudden-onset confusion, agitation, and rapid breathing. The roommate reports that the patient has been highly stressed studying for final examinations and recently complained of a continuous ringing sensation in her ears. The patient has no known past medical history and takes no medications. Her temperature is $37.9^\circ\text{C}$ ( $100.2^\circ\text{F}$ ), blood pressure is $112/70 \text{ mm Hg}$ , pulse is $118/\text{min}$ , and respirations are $32/\text{min}$ . Physical examination reveals a diaphoretic, anxious woman with deep, rapid breaths. There are no focal neurologic deficits.

Laboratory studies show the following:

Test	Result
Serum sodium	$140 \text{ mEq/L}$
Serum potassium	$3.6 \text{ mEq/L}$
Serum chloride	$104 \text{ mEq/L}$
Serum bicarbonate	$12 \text{ mEq/L}$
Blood urea nitrogen	$16 \text{ mg/dL}$
Serum creatinine	$1.0 \text{ mg/dL}$
Blood glucose	$95 \text{ mg/dL}$

Arterial blood gas on room air:

Test	Result
pH	$7.44$
$\text{PaCO}_2$	$18 \text{ mm Hg}$
$\text{PaO}_2$	$98 \text{ mm Hg}$

Which of the following is the most appropriate next step in management?

Intravenous sodium bicarbonate

Endotracheal intubation

Intravenous regular insulin and normal saline

Intravenous ceftriaxone and vancomycin

Intravenous furosemide and noninvasive positive pressure ventilation

Show answer & explanation

Answer: Intravenous sodium bicarbonate

Answer

Intravenous sodium bicarbonate is the correct management.

The patient's presentation of tinnitus, tachypnea, fever, and confusion, combined with a mixed high anion gap metabolic acidosis and primary respiratory alkalosis, is classic for acute salicylate toxicity. Salicylates directly stimulate the medullary respiratory center (causing a primary respiratory alkalosis) and uncouple oxidative phosphorylation (causing an accumulation of organic acids and a primary high anion gap metabolic acidosis). The most appropriate next step in management is the administration of intravenous sodium bicarbonate. This alkalinizes both the serum and the urine. Serum alkalinization keeps salicylates in their deprotonated (ionized) form, preventing them from crossing the blood-brain barrier and worsening central nervous system toxicity. Urine alkalinization traps the ionized salicylates in the renal tubules, significantly enhancing their renal excretion.

Step-by-Step Solution

Calculate the anion gap to identify the primary metabolic disturbance.

\text{AG} = 140 - (104 + 12) = 24 \text{ mEq/L}

, indicating a high anion gap metabolic acidosis.

An elevated anion gap is the first step in diagnosing the etiology of a metabolic acidosis.

Apply Winter's formula to determine the expected respiratory compensation.

\text{Expected PaCO}_2 = 1.5 \times 12 + 8 = 26 \pm 2 \text{ mm Hg}

This determines if the respiratory response is purely compensatory or if a secondary acid-base disorder is present.

Compare the actual

\text{PaCO}_2

to the expected

\text{PaCO}_2

The actual

\text{PaCO}_2

(

18 \text{ mm Hg}

) is significantly lower than the expected range (

24-28 \text{ mm Hg}

A lower than expected

\text{PaCO}_2

confirms the presence of a concomitant primary respiratory alkalosis.

Synthesize the mixed acid-base disorder with the clinical presentation.

The combination of tinnitus, fever, tachypnea, agitation, and a mixed high anion gap metabolic acidosis with primary respiratory alkalosis strongly indicates salicylate toxicity.

Recognizing this toxidrome is essential to avoid potentially fatal mismanagement.

Select the appropriate targeted therapy for salicylate toxicity.

Intravenous sodium bicarbonate is selected to alkalinize the blood and urine.

Alkalinization traps the salicylate ion in the renal tubules, enhancing excretion and reducing central nervous system toxicity.

Key Concept

Patients with acute salicylate toxicity present with a classic mixed acid-base disorder: a primary respiratory alkalosis (due to direct medullary stimulation) and a high anion gap metabolic acidosis (due to uncoupling of oxidative phosphorylation). Management centers on urine alkalinization with intravenous sodium bicarbonate.

Question 1289Question →

A $71$ -year-old man is evaluated on hospital day $3$ for ongoing management of acute pyelonephritis and concurrent bacteremia. At the time of admission, he presented with a temperature of $39.4^\circ\text{C}$ ( $102.9^\circ\text{F}$ ), heart rate of $112 \text{ /min}$ , and blood pressure of $88/54 \text{ mm Hg}$ . Following aggressive fluid resuscitation, he was empirically started on intravenous ceftriaxone. He has demonstrated significant clinical improvement, currently reporting minimal flank pain. Today, his temperature is $37.5^\circ\text{C}$ ( $99.5^\circ\text{F}$ ) and blood pressure is $122/78 \text{ mm Hg}$ . Blood and urine cultures obtained prior to antibiotic initiation both demonstrate heavy growth of *Enterobacter cloacae*. The microbiology laboratory reports the following minimum inhibitory concentrations (MIC) and interpretations for the isolate:

Antimicrobial Agent	Interpretation
Ampicillin	Resistant
Cefazolin	Resistant
Ceftriaxone	Susceptible
Cefepime	Susceptible
Piperacillin-tazobactam	Susceptible
Meropenem	Susceptible

Which of the following is the most appropriate next step in pharmacotherapy?

Switch to intravenous cefepime

Continue intravenous ceftriaxone

Switch to intravenous meropenem

Switch to intravenous piperacillin-tazobactam

Add oral clavulanate to the current regimen

Show answer & explanation

Answer: Switch to intravenous cefepime

Answer

The most appropriate next step is to switch to intravenous cefepime.

The correct approach involves recognizing that *Enterobacter cloacae* produces an inducible chromosomal AmpC beta-lactamase. Third-generation cephalosporins (like ceftriaxone) act as strong inducers of this enzyme and are subsequently hydrolyzed by it, leading to treatment failure even when in vitro testing reports them as susceptible. Cefepime, a fourth-generation cephalosporin, is uniquely stable against AmpC hydrolysis and is a very weak inducer of the enzyme. According to current infectious disease guidelines, cefepime is the definitive drug of choice for invasive AmpC-producing infections (like bacteremia) that are susceptible to it.

Step-by-Step Solution

Identify the pathogen's intrinsic resistance profile.

*Enterobacter cloacae* is recognized as a SPACE organism carrying an inducible chromosomal AmpC beta-lactamase gene.

Understanding the pathogen's resistance mechanisms is critical because in vitro susceptibility does not always predict in vivo efficacy.

Evaluate the current empiric therapy (ceftriaxone) against the pathogen's profile.

Although ceftriaxone tests as 'Susceptible' in vitro, it is a strong inducer of AmpC and is easily hydrolyzed by it.

Continuing a third-generation cephalosporin for an AmpC producer risks selecting for derepressed mutant strains, leading to inevitable clinical failure.

Select the optimal definitive therapy that balances efficacy and antimicrobial stewardship.

Cefepime is chosen over meropenem and piperacillin-tazobactam.

Cefepime (a fourth-generation cephalosporin) is highly stable against AmpC enzymes and is preferred over carbapenems to prevent the emergence of multi-drug resistant organisms.

Key Concept

Management of invasive infections caused by AmpC-producing Enterobacterales (e.g., *Enterobacter cloacae*) requires transitioning from third-generation cephalosporins to cefepime to prevent inducible resistance, even when in vitro testing suggests broader susceptibility.

Estimated Time:1m 30s

Question 1290Question →

A 61-year-old female is evaluated in the hospital on day 4 of admission for a non-healing right foot ulcer. She has a 15-year history of type 2 diabetes mellitus complicated by severe peripheral neuropathy. On admission, she presented with localized erythema, warmth, and purulent drainage from a deep plantar ulcer. A probe-to-bone test was positive. She was hemodynamically stable with no signs of systemic inflammatory response syndrome. A deep bone biopsy was obtained for culture, and she was empirically started on intravenous vancomycin and piperacillin-tazobactam.

Today, her erythema has significantly improved. She remains afebrile and hemodynamically stable. The bone biopsy culture results are now available, demonstrating heavy growth of two organisms. Blood cultures show no growth.

The antimicrobial susceptibility report is as follows:

Antimicrobial	Proteus mirabilis	Bacteroides fragilis
Ampicillin	Resistant	Not tested
Cefazolin	Resistant	Not tested
Ceftriaxone	Susceptible	Not tested
Ciprofloxacin	Resistant	Not tested
Clindamycin	Not tested	Resistant
Metronidazole	Not tested	Susceptible
Meropenem	Susceptible	Susceptible
Piperacillin-tazobactam	Susceptible	Susceptible

Based on these results, which of the following is the most appropriate next step in this patient's antimicrobial management?

Discontinue vancomycin and continue piperacillin-tazobactam.

Discontinue current antibiotics and initiate meropenem.

Discontinue current antibiotics and initiate ceftriaxone and metronidazole.

Continue the current empiric regimen of vancomycin and piperacillin-tazobactam.

Discontinue current antibiotics and initiate ciprofloxacin and metronidazole.

Show answer & explanation

Answer: Discontinue current antibiotics and initiate ceftriaxone and metronidazole.

Answer

Discontinue current antibiotics and initiate ceftriaxone and metronidazole.

The patient has diabetic foot osteomyelitis. Her bone culture grew Proteus mirabilis (a Gram-negative rod) and Bacteroides fragilis (an obligate anaerobe). Antimicrobial stewardship principles dictate that once culture and susceptibility data are available, broad-spectrum empiric therapy should be de-escalated to the narrowest-spectrum effective regimen. P. mirabilis is susceptible to ceftriaxone, which is a third-generation cephalosporin with a narrower spectrum than piperacillin-tazobactam or meropenem (it lacks anti-pseudomonal activity). B. fragilis is susceptible to metronidazole, a targeted anaerobic agent. Therefore, the combination of ceftriaxone and metronidazole provides optimal, targeted coverage for both isolated pathogens while minimizing collateral damage to the microbiome.

Step-by-Step Solution

Identify the clinical diagnosis and the organisms isolated.

The patient has diabetic foot osteomyelitis caused by Proteus mirabilis and Bacteroides fragilis.

A positive probe-to-bone test in a deep diabetic ulcer indicates osteomyelitis, which is confirmed by heavy growth on deep bone biopsy culture.

Analyze the antimicrobial susceptibility data for both organisms.

P. mirabilis is susceptible to ceftriaxone, meropenem, and piperacillin-tazobactam, but resistant to ampicillin, cefazolin, and ciprofloxacin. B. fragilis is susceptible to metronidazole, meropenem, and piperacillin-tazobactam.

Selecting an effective regimen requires matching the susceptibility profiles of all isolated pathogens.

Apply antimicrobial stewardship principles to select the optimal definitive therapy.

Ceftriaxone (for P. mirabilis) plus metronidazole (for B. fragilis) is selected.

This combination is the narrowest-spectrum regimen that effectively treats both organisms, avoiding the unnecessary use of anti-pseudomonal agents or carbapenems.

Key Concept

In patients with polymicrobial infections, empiric broad-spectrum antibiotics should be de-escalated to the narrowest-spectrum regimen effective against all isolated organisms to promote antimicrobial stewardship and prevent resistance.

Question 1291Question →

An 81-year-old man is brought to the emergency department from a skilled nursing facility due to sudden-onset severe respiratory distress that began 2 hours ago. The nursing facility staff reports that he has been coughing up pink, frothy sputum. His medical history includes hypertension, coronary artery disease, and severe chronic obstructive pulmonary disease. He is currently prescribed inhaled tiotropium, as-needed albuterol, aspirin, and metoprolol. Upon arrival, his temperature is 37.0°C (98.6°F), blood pressure is 172/98 mmHg, pulse is 114/min, and respirations are 28/min. Pulse oximetry is 86% on room air. Physical examination reveals an anxious patient sitting upright and using accessory muscles of respiration. Jugular venous pulsations are visible 6 cm above the sternal angle. Auscultation of the chest reveals diffuse bilateral crackles extending to the apices and scattered expiratory wheezing. Cardiac examination reveals a regular tachycardia and a distinct third heart sound. Bilateral lower extremity pitting edema is present. A point-of-care urinalysis shows positive leukocyte esterase, positive nitrites, and 20 white blood cells per high-power field. Which of the following is the most appropriate initial pharmacological management for this patient?

Intravenous bumetanide

Intravenous methylprednisolone

Nebulized ipratropium bromide

Intravenous piperacillin-tazobactam

Intravenous levofloxacin

Show answer & explanation

Answer: Intravenous bumetanide

Answer

Administration of a loop diuretic, such as intravenous bumetanide, is the most appropriate initial therapy.

The correct intervention focuses on rapid volume offloading. The patient's presentation—sudden severe dyspnea, hypertension, pink frothy sputum, JVD, bilateral crackles, and an S3 gallop—is the classic clinical picture of acute decompensated heart failure (ADHF) presenting as cardiogenic pulmonary edema. Intravenous loop diuretics (like bumetanide or furosemide) are the mainstay of initial pharmacological therapy because they rapidly reduce intravascular volume and venous return, alleviating pulmonary congestion.

Step-by-Step Solution

Analyze the patient's acute respiratory presentation and vital signs.

The patient has severe hypoxia, tachypnea, severe hypertension, and is coughing up pink, frothy sputum.

Identifying the acuity and characteristics of the respiratory failure helps narrow the differential diagnosis.

Evaluate the physical examination findings to differentiate the cause of dyspnea.

Elevated jugular venous pressure, bilateral crackles, an S3 gallop, and lower extremity edema strongly indicate volume overload and left ventricular failure.

Patients with a history of COPD can present with wheezing during heart failure exacerbations (cardiac asthma), but an S3 gallop and JVD are specific to a cardiogenic etiology.

Determine the significance of the abnormal urinalysis in the absence of fever or specific urinary symptoms.

The abnormal urinalysis in an elderly nursing home resident without systemic infectious signs likely represents asymptomatic bacteriuria.

Avoidance of unnecessary antibiotics (antibiotic stewardship) is critical unless the patient has a clear symptomatic infection.

Select the most appropriate initial management based on the primary diagnosis.

The primary issue is acute decompensated heart failure (ADHF); therefore, intravenous loop diuretics are the first-line pharmacological treatment.

Loop diuretics decrease fluid volume and venous return (preload), rapidly improving pulmonary congestion and oxygenation.

Key Concept

Patients with acute decompensated heart failure often present with sudden severe dyspnea, hypertension, an S3 gallop, and pulmonary crackles; initial management prioritizes preload reduction with intravenous loop diuretics.

Question 1292Question →

Match each clinical presentation of an adverse transfusion event to its primary underlying pathophysiologic mechanism.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Rigors and isolated fever match with cytokine accumulation (FNHTR). Shock and wheezing match with anti-IgA mast cell degranulation (Anaphylaxis). Hypoxemia with normal venous pressure matches with neutrophil activation in the pulmonary vasculature (TRALI). Hypertension and an S3 gallop match with rapid intravascular volume expansion (TACO).

Transfusion reactions are distinguished by their specific pathophysiology and clinical manifestations. Febrile non-hemolytic reactions are driven by storage cytokines causing isolated fever. Anaphylactic reactions occur due to preformed anti-IgA antibodies triggering mast cells, leading to shock and urticaria. TRALI and TACO both cause acute respiratory distress; however, TRALI is an inflammatory capillary leak caused by donor antibodies, whereas TACO is hydrostatic pulmonary edema strictly caused by volume overload in susceptible individuals.

Step-by-Step Solution

Evaluate the timing and systemic nature of the symptom onset in relation to the transfusion.

Identifies whether the reaction is isolated to fever, includes allergic/anaphylactic symptoms, or is primarily respiratory.

Categorizing the primary symptom cluster narrows down the potential pathophysiologic mechanisms.

Differentiate the two causes of acute pulmonary edema following transfusion (TRALI vs. TACO).

The scenario with normal central venous pressure indicates non-cardiogenic etiology (TRALI), while the scenario with hypertension and an S3 gallop indicates a cardiogenic etiology (TACO).

TRALI is caused by inflammatory capillary leak, whereas TACO is driven by hydrostatic volume overload.

Differentiate isolated febrile reactions from severe allergic shock.

The presentation with fever and rigors alone matches FNHTR, while the presentation with hypotension, wheezing, and urticaria matches anaphylaxis.

Cytokine accumulation causes benign febrile reactions, whereas preformed IgE antibodies against donor IgA cause immediate, life-threatening anaphylactic shock.

Key Concept

Diagnosis and pathophysiology of acute non-hemolytic transfusion reactions

Question 1293Question →

A 68-year-old woman is brought to the emergency department by her daughter due to a high fever, severe diffuse headache, and progressive confusion over the past 24 hours. Her temperature is 39.2°C (102.6°F), blood pressure is 110/70 mm Hg, and heart rate is 115/min. She is lethargic but arouses to painful stimuli. Physical examination reveals marked nuchal rigidity. Ophthalmoscopic examination demonstrates bilateral blurring of the optic disc margins. Arrange the following steps in the most appropriate chronological order for the immediate management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Obtain two sets of peripheral blood cultures, administer empiric intravenous antibiotics and dexamethasone, perform a noncontrast CT scan of the head, and finally perform a lumbar puncture.

In a patient with suspected bacterial meningitis, the presence of 'red flags'—such as papilledema, altered mental status, focal neurologic deficits, new-onset seizures, or an immunocompromised state—mandates a head CT prior to a lumbar puncture to avoid brain herniation. Because the CT scan and subsequent lumbar puncture take time, empiric antibiotics and adjunctive dexamethasone must not be delayed. The correct protocol is to immediately draw blood cultures, promptly administer empiric antibiotics and dexamethasone, obtain the head CT, and finally perform the lumbar puncture once the CT verifies it is safe.

Step-by-Step Solution

Recognize the clinical presentation of bacterial meningitis with signs of elevated intracranial pressure.

The patient has fever, neck stiffness, altered mental status, and papilledema.

Identifying red flags (altered mental status, papilledema) determines that a CT scan is required before a lumbar puncture.

Prioritize pathogen identification without delaying treatment.

Obtain two sets of peripheral blood cultures.

Blood cultures must be drawn before administering antibiotics to ensure optimal yield, taking only minutes to perform.

Initiate life-saving therapy immediately.

Administer empiric intravenous antibiotics and dexamethasone.

Because neuroimaging will delay the lumbar puncture, empiric therapy must be started immediately to reduce mortality and neurologic sequelae.

Ensure the safety of the definitive diagnostic procedure.

Perform a noncontrast CT scan of the head.

Neuroimaging evaluates for focal mass lesions or severe edema that could cause cerebral herniation during cerebrospinal fluid removal.

Obtain definitive diagnostic samples.

Perform a lumbar puncture.

Once the CT scan confirms it is safe, cerebrospinal fluid is collected for cell count, glucose, protein, Gram stain, and culture.

Key Concept

Management algorithm for suspected bacterial meningitis with indications for neuroimaging.

Question 1294Question →

Systemic vasculitides often present with overlapping multi-organ involvement, but distinct clinicopathologic features and specific infectious associations can differentiate them. Match each patient's clinical presentation with the most likely specific systemic vasculitis diagnosis.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The correct pairings match Granulomatosis with polyangiitis to the patient with cavitary lung lesions, epistaxis, and granulomas; Eosinophilic granulomatosis with polyangiitis to the patient with asthma, eosinophilia, and wrist drop; Polyarteritis nodosa to the patient with hepatitis B, mesenteric microaneurysms, and lung sparing; and Cryoglobulinemic vasculitis to the patient with hepatitis C, palpable purpura, and low C4.

Each systemic vasculitis presents with a unique clinicopathologic signature. Granulomatosis with polyangiitis (GPA) is characterized by necrotizing granulomatous inflammation affecting the upper airway, lower airway, and kidneys. Eosinophilic granulomatosis with polyangiitis (EGPA) is distinguished by an allergic phenotype, adult-onset asthma, and marked eosinophilia. Polyarteritis nodosa (PAN) affects medium-sized arteries, causing microaneurysms and tissue ischemia (e.g., mesenteric), uniquely associating with Hepatitis B while sparing the pulmonary circulation. Cryoglobulinemic vasculitis is strongly linked to Hepatitis C, presenting with palpable purpura, arthralgias, and mixed cryoglobulins that consume complement (low C4) and exhibit rheumatoid factor activity.

Step-by-Step Solution

Analyze the first clinical presentation focusing on upper/lower respiratory tract symptoms and renal findings.

The triad of recurrent epistaxis, cavitary lung lesions, and glomerulonephritis with granulomatous inflammation identifies Granulomatosis with polyangiitis (GPA).

GPA is defined by necrotizing granulomatous inflammation of the respiratory tract and necrotizing glomerulonephritis.

Evaluate the second presentation noting the atopic history and neurological deficits.

The combination of refractory asthma, prominent peripheral eosinophilia, and mononeuritis multiplex (wrist drop) identifies Eosinophilic granulomatosis with polyangiitis (EGPA).

EGPA uniquely features eosinophil-rich and granulomatous inflammation prominently involving the respiratory tract, heavily associated with asthma and atopy.

Review the third presentation emphasizing viral associations and involved vascular beds.

The association with hepatitis B, presentation of mesenteric ischemia (postprandial pain), angiographic microaneurysms, and the specific lack of lung involvement point to Polyarteritis nodosa (PAN).

PAN is a medium-vessel vasculitis that characteristically spares the pulmonary capillaries while frequently targeting mesenteric, renal, and dermatologic vessels.

Examine the fourth presentation considering laboratory anomalies and dermatologic findings.

The triad of palpable purpura, arthralgias, and fatigue in the setting of hepatitis C, along with a positive rheumatoid factor and low C4 complement levels, identifies Cryoglobulinemic vasculitis.

Mixed cryoglobulinemia is largely driven by hepatitis C infection, and the cryoglobulins consume complement (especially C4) while demonstrating rheumatoid factor activity.

Key Concept

Differentiating systemic vasculitides based on classic clinical phenotypes, histopathology, and associated infectious etiologies.

Question 1295Question →

Match each clinical presentation to the most appropriate, evidence-based therapeutic intervention, taking into account current clinical guidelines and antimicrobial stewardship principles.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The correct matches pair each specific infectious presentation with the management step that adheres to current antimicrobial stewardship guidelines: fidaxomicin for initial C. difficile, nitrofurantoin for cystitis with high TMP-SMX resistance, doxycycline for syphilis with penicillin anaphylaxis (non-pregnant), and simple incision and drainage for an uncomplicated abscess.

Each correct pairing reflects the current standard of care regarding infectious disease management and antimicrobial stewardship. Fidaxomicin targets C. difficile while reducing recurrence. Nitrofurantoin avoids empiric failure in areas of high TMP-SMX resistance. Doxycycline provides a safe, non-beta-lactam alternative for early syphilis in non-pregnant individuals. Incision and drainage without antibiotics prevents unnecessary antimicrobial exposure for simple abscesses.

Step-by-Step Solution

Analyze the Clostridioides difficile presentation.

Identify that current IDSA guidelines prioritize fidaxomicin (or oral vancomycin) over metronidazole for initial episodes.

Fidaxomicin provides a narrow spectrum that spares normal gut flora and significantly reduces recurrence rates.

Evaluate the uncomplicated cystitis scenario with local E. coli data.

Recognize that TMP-SMX should be avoided since resistance exceeds the

20\%

threshold.

Empiric therapy must have a high likelihood of success; nitrofurantoin or fosfomycin are preferred when TMP-SMX resistance is high.

Assess the treatment options for primary syphilis in the context of anaphylaxis.

Determine that oral doxycycline is the standard alternative therapy.

Because the patient is not pregnant, penicillin desensitization is unnecessary, and a 14-day course of doxycycline is highly effective.

Determine the necessity of antibiotics for the cutaneous abscess.

Conclude that no antibiotics are needed.

The patient is afebrile and immunocompetent with no systemic inflammatory signs, making incision and drainage alone the gold standard.

Key Concept

Targeted therapeutic interventions and antimicrobial stewardship in general internal medicine

Estimated Time:2m 0s

Question 1296Question →

A 68-year-old woman presents to the clinic for the management of right knee pain that has been progressively worsening over the last 3 years. The pain is exacerbated by prolonged standing or walking and is relieved by rest. She has no other medical conditions and currently takes no medications. Her body mass index is 31 kg/m². Examination of the right knee reveals bony hypertrophy, crepitus on active range of motion, and a minimal, cool effusion. X-rays demonstrate medial joint space narrowing and marginal osteophytes. She is highly motivated to improve her symptoms but wants to understand the step-by-step treatment approach. Arrange the following management steps in the most appropriate sequential order of escalation for this patient's condition, starting from the most conservative initial step to the most definitive treatment.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of therapy escalation for osteoarthritis of the knee is: 1) Exercise and weight loss, 2) Topical NSAIDs, 3) Oral NSAIDs, 4) Intraarticular glucocorticoid injections, 5) Total knee arthroplasty.

The management of osteoarthritis follows a step-up approach to balance efficacy with the risk of adverse effects. Nonpharmacologic interventions, particularly weight loss and physical exercise, are universally recommended as the foundational first step for all patients. If symptoms persist, pharmacotherapy is initiated. For superficial joints such as the knee, topical NSAIDs (e.g., topical diclofenac) are strongly preferred as the initial pharmacologic agent because they provide comparable pain relief to oral NSAIDs but carry a significantly lower risk of systemic gastrointestinal, cardiovascular, and renal toxicities. If topical therapy fails to provide adequate relief, escalating to oral NSAIDs is the next appropriate step. For patients who continue to experience moderate-to-severe symptoms despite oral medications, intraarticular glucocorticoid injections are indicated. Finally, when all conservative and medical options have been exhausted, referral for total knee arthroplasty serves as the definitive treatment.

Step-by-Step Solution

Identify the primary diagnosis from the clinical presentation.

Osteoarthritis of the knee.

The patient has chronic, activity-dependent joint pain, age over 50, crepitus, bony hypertrophy, and classic radiographic findings.

Determine the first-line foundational treatment for the condition.

Weight management and structured physical exercise.

Nonpharmacologic therapy is always the initial and concurrent step for all patients with symptomatic osteoarthritis.

Select the safest initial pharmacologic therapy.

Topical NSAIDs.

For superficial joints like the knee, topical NSAIDs are preferred over oral forms to minimize the risk of systemic gastrointestinal, cardiovascular, and renal side effects.

Determine the next step if topical therapy is inadequate.

Oral NSAIDs.

Oral NSAIDs serve as step-up therapy when topical agents are insufficient, assuming the patient lacks absolute contraindications.

Identify the therapy for refractory pain prior to surgical consideration.

Intraarticular glucocorticoid injection.

This provides effective short-to-medium-term relief for moderate-to-severe pain refractory to oral medications or during acute symptom flares.

Determine the definitive end-stage treatment.

Surgical evaluation for arthroplasty.

Joint replacement is reserved for severe, refractory disease with significant functional impairment after all conservative medical options are exhausted.

Key Concept

Stepwise escalation of therapy in knee osteoarthritis prioritizes safety and local interventions before advancing to systemic medications and surgery.

Estimated Time:1m 30s

Question 1297Question →

Match each clinical presentation of an immunocompromised patient with the most appropriate primary pharmacotherapy for their underlying condition.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Invasive aspergillosis (halo sign) pairs with voriconazole. Cryptococcal meningitis (encapsulated yeast, high opening pressure) pairs with liposomal amphotericin B and flucytosine. Progressive multifocal leukoencephalopathy (non-enhancing white matter lesions) pairs with combination antiretroviral therapy. Cytomegalovirus (post-transplant cytopenias, beta-herpesvirus) pairs with ganciclovir or valganciclovir.

Each specific opportunistic infection requires a targeted primary approach: voriconazole for invasive aspergillosis, amphotericin B and flucytosine for induction in cryptococcal meningitis, cART for immune reconstitution in PML, and ganciclovir for CMV.

Step-by-Step Solution

Analyze each clinical vignette to identify the most likely opportunistic pathogen based on the host immune defect and specific clinical/radiographic clues.

Identified pathogens: Aspergillus species, Cryptococcus neoformans, JC virus, and Cytomegalovirus.

Accurate pathogen identification is required to select targeted therapy in immunocompromised hosts.

Determine the first-line pharmacologic intervention for each identified pathogen.

Aspergillus requires voriconazole; Cryptococcus requires amphotericin B plus flucytosine for induction; JC virus requires immune reconstitution via cART; CMV requires ganciclovir or valganciclovir.

Current treatment guidelines dictate these specific standard-of-care treatments to maximize efficacy and survival.

Match the clinical presentations with their corresponding therapies.

The final pairings correctly align the diagnosis with the specific management.

This completes the requirements of the matching exercise.

Key Concept

Targeted management of opportunistic infections in immunocompromised patients depends heavily on correlating specific radiographic and laboratory clues with the causative organism.

Estimated Time:1m 30s

Question 1298Question →

A 54-year-old woman is brought to the emergency department by her partner due to progressive confusion, a severe generalized headache, and fever for the past 14 hours. Her past medical history is significant for severe rheumatoid arthritis, for which she currently takes methotrexate and infliximab. Her temperature is $39.4^\circ\text{C}$ ( $102.9^\circ\text{F}$ ), blood pressure is $105/65\text{ mmHg}$ , pulse is $118/\text{min}$ , and respiratory rate is $22/\text{min}$ . On physical examination, she is lethargic but localizes to painful stimuli. She has marked nuchal rigidity and positive Kernig and Brudzinski signs. Fundoscopic examination reveals blurring of the bilateral optic disc margins.

Arrange the following management steps in the most appropriate chronological order for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Obtain peripheral blood cultures, 2) Administer empiric intravenous antibiotics and corticosteroids, 3) Perform a noncontrast CT scan of the head, 4) Perform a lumbar puncture, and 5) De-escalate to targeted antimicrobial therapy.

The correct management algorithm for suspected bacterial meningitis requires immediate blood cultures, followed by empiric antibiotics and dexamethasone. If the patient has 'red flag' indications (e.g., papilledema, focal neurologic deficits, altered mental status, immunocompromise, new-onset seizure), a CT head must be performed prior to a lumbar puncture to rule out mass effect and prevent herniation. Crucially, antibiotics must not be delayed for the CT or LP. Once the CT clears the patient, the LP is performed, and antibiotics are later tailored based on culture results.

Step-by-Step Solution

Identify the primary diagnosis and its severity.

The patient presents with the classic triad of fever, altered mental status, and nuchal rigidity, highly suggestive of acute bacterial meningitis.

Rapid identification of suspected bacterial meningitis dictates an immediate, life-saving management algorithm.

Determine if the patient has indications for a CT scan prior to a Lumbar Puncture (LP).

The patient requires a CT before LP due to three distinct indications: immunocompromised status (infliximab/methotrexate), altered mental status, and papilledema (blurred optic disc margins).

Performing an LP in the setting of increased intracranial pressure from a mass lesion or severe edema can cause fatal uncal herniation.

Determine the proper sequence of diagnostics and therapeutics given the need for a CT scan.

When a CT is required before an LP, empiric antibiotics must NOT be delayed. Blood cultures should be drawn first, followed immediately by empiric antibiotics and dexamethasone, before sending the patient to the CT scanner.

Every hour of delay in administering antibiotics in bacterial meningitis increases mortality. Blood cultures take minutes and should precede antibiotics to maximize pathogen recovery.

Select the appropriate empiric antibiotic regimen.

The correct regimen is Ceftriaxone, Vancomycin, and Ampicillin (along with Dexamethasone).

Ampicillin must be added to the standard ceftriaxone/vancomycin regimen for patients >50 years old or those who are immunocompromised (as in this patient on biologic therapy) to cover Listeria monocytogenes.

Sequence the remaining steps after initial stabilization.

After CT clears the patient, perform the LP. Finally, de-escalate antibiotics once cultures result.

Definitive diagnosis requires CSF analysis, and long-term management requires targeted therapy to prevent antibiotic resistance.

Key Concept

Algorithm for suspected bacterial meningitis with indications for CT before Lumbar Puncture

Question 1299Question →

Match each hematologic disorder with its most characteristic peripheral blood smear finding and associated laboratory profile.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Thrombotic thrombocytopenic purpura matches with numerous schistocytes and normal PT. Chronic myeloid leukemia matches with leukocytosis, full myeloid spectrum, and absolute basophilia. Lead poisoning matches with microcytic red blood cells and coarse basophilic stippling. Multiple myeloma matches with rouleaux formation.

Each hematologic condition presents with unique, pathognomonic peripheral smear findings driven by their distinct underlying pathophysiology. Matching these correctly confirms an understanding of both visual hematology morphology and disease mechanisms.

Step-by-Step Solution

Analyze the pathophysiology of Thrombotic thrombocytopenic purpura (TTP)

Identify that TTP causes microvascular platelet thrombi without coagulation factor consumption.

This directly matches the smear finding of red blood cell fragmentation (schistocytes) alongside thrombocytopenia but normal PT/PTT.

Evaluate the cellular proliferation pattern in Chronic myeloid leukemia (CML)

Identify unregulated myeloid lineage expansion, including basophils and eosinophils.

The presence of the full spectrum of immature myeloid cells and absolute basophilia confirms the diagnosis and differentiates it from a leukemoid reaction.

Identify the toxic effects of Lead poisoning on erythrocytes

Recognize the inhibition of RNA degradation leading to retained ribosomal aggregates.

These aggregates are visually represented as coarse basophilic stippling within microcytic red blood cells.

Assess the impact of paraproteinemia in Multiple myeloma

Identify the neutralization of the red blood cell zeta potential.

This loss of repulsive surface charge causes erythrocytes to adhere to one another in linear stacks, forming rouleaux.

Key Concept

Characteristic peripheral blood smear findings are crucial for distinguishing between various hematologic and oncologic disorders, reflecting their unique underlying pathophysiologies.

Question 1300Question →

During morning rounds on the hematology-oncology ward, a 45-year-old female patient is noted to have a temperature of $38.8^\circ C$ ( $101.8^\circ F$ ). She was admitted two weeks ago for induction chemotherapy to treat acute myeloid leukemia. The patient reports moderate fatigue but denies any localizing symptoms such as cough, dysuria, abdominal pain, or skin changes. Vital signs show a blood pressure of $115/75$ mm Hg, a heart rate of $105$ /min, and a respiratory rate of $16$ /min. Physical examination demonstrates an indwelling central venous catheter with clean, non-erythematous margins and no tenderness to palpation. Her lungs are clear to auscultation, and her abdomen is soft and non-tender. Laboratory analysis reveals a leukocyte count of $400/\mu L$ with an absolute neutrophil count of $50/\mu L$ . After drawing blood cultures from the catheter and a peripheral vein, which of the following is the most appropriate initial pharmacologic management?

Intravenous cefepime

Intravenous piperacillin-tazobactam and vancomycin

Intravenous ceftriaxone

Oral ciprofloxacin and amoxicillin-clavulanate

Intravenous meropenem and micafungin

Show answer & explanation

Answer: Intravenous cefepime

Answer

Intravenous cefepime

Febrile neutropenia is a medical emergency characterized by a temperature of

\geq 38.3^\circ C

(

101.0^\circ F

) and an absolute neutrophil count (ANC)

< 500/\mu L

. Because patients lack the white blood cells necessary to mount a standard inflammatory response, an infection can rapidly progress to fatal sepsis. Initial empiric therapy must include an intravenous bactericidal agent with reliable activity against Pseudomonas aeruginosa. Current guidelines recommend monotherapy with an antipseudomonal beta-lactam, such as cefepime, meropenem, or piperacillin-tazobactam, for high-risk patients (e.g., those with hematologic malignancies undergoing induction). The patient in this vignette is hemodynamically stable and has no specific indications requiring MRSA or antifungal coverage, making antipseudomonal monotherapy the most appropriate next step.

Step-by-Step Solution

Identify the primary clinical syndrome and severity.

The patient has febrile neutropenia (fever > 38.3 C and ANC < 500) and is classified as high-risk due to acute myeloid leukemia induction therapy.

Risk stratification determines whether the patient requires inpatient intravenous therapy (high-risk) or can be managed with outpatient oral therapy (low-risk).

Determine the necessary empiric antimicrobial spectrum.

Therapy must rapidly and reliably cover serious Gram-negative bacilli, specifically Pseudomonas aeruginosa, as well as common Gram-positive organisms.

Pseudomonas aeruginosa can cause rapidly fatal sepsis in profoundly neutropenic hosts if not covered immediately.

Assess if specific criteria for empiric Methicillin-resistant Staphylococcus aureus (MRSA) or fungal coverage are met.

The patient is hemodynamically stable, has a clean catheter site, no pneumonia, and this is her first day of fever. Therefore, neither MRSA nor fungal coverage is indicated yet.

Antibiotic stewardship principles dictate avoiding unnecessarily broad agents (like vancomycin) to prevent toxicity and the emergence of resistant organisms.

Select the appropriate pharmacologic agent based on the established parameters.

An intravenous antipseudomonal beta-lactam as monotherapy (such as cefepime, meropenem, or piperacillin-tazobactam) is the correct choice.

This provides the required bactericidal activity against Pseudomonas without violating stewardship principles.

Key Concept

Patients with high-risk febrile neutropenia require immediate empiric intravenous monotherapy with an antipseudomonal beta-lactam (e.g., cefepime, meropenem, piperacillin-tazobactam); vancomycin should not be routinely added without specific indications.

PreviousPage 65 / 158Next

Internal Medicine

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept